← Study Library
Animal · 2004
Preclinicalcounts toward this tierProtective effects of pentadecapeptide BPC 157 on gastric ulcer in rats
Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ · World Journal of Gastroenterology
Preclinicalcounts toward this tier
Both routes reduced ulcer area, with inhibition ratios of 45.7–65.6% at 400–800 ng/kg (p<0.01 versus control); the intramuscular route worked at a lower effective dose than the intragastric, and continued dosing rebuilt glandular epithelium and granulation tissue in the chronic model.
- Population
- Rats with acute (three models) and chronic acetate-induced gastric ulcers
- Intervention
- BPC 157 200–800 ng/kg intramuscularly or intragastrically
- Comparator
- Excipient and saline controls, with famotidine as an active reference
- Limitations
- Independent Chinese group; the paper also reports numerically higher inhibition than famotidine, but no statistical test of that comparison is given in the retrievable record, so the head-to-head is not treated as a finding here.
Cited by
1 entry references this study
- BPC-157PRECL.
Peptides → Preclinical & experimental